Intracoronary cyclic-GMP and cyclic-AMP during percutaneous transluminal coronary angioplasty

International Journal of Cardiology

Volumn 53, Issue 3, 1996, Pages 227-232

  Kremastinos, Dimitrios Th ^a,c   Iliodromitis, Efstathios K ^a   Markianos, Manolis ^b   Apostolou, Thomas S ^a   Kyriakides, Zenon S ^a   Karavolias, George K ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Cyclic guanosine monophosphate (c GMP); Percutaneous transluminal coronary angioplasty

Indexed keywords

CYCLIC AMP; CYCLIC GMP;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029934604     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(95)02539-1     Document Type: Article

References (28)

1. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986; 78: 1-5.
2. Francis GS. Nitroglycerin, nitroprusside and endothelium-derived relaxing factor. J Assoc Clin Chem 1988; 11: 1325-1326.
3. Murad F, Letiman DC, Mennett BMK, Molina C, Waldman SA. Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic-GMP in vasodilation. Am J Med Sci 1987; 294: 139-143.
4. Strasser RH, Marquetant R, Kuebler W. Adrenergic receptors and sensitisation of adenylyl cyclase in acute myocardial ischemia. Circulation 1990; 92(Suppl. II): 223-229).
5. Ashman DF, Lipton R, Milicow M, Price T. Isolation of adenosine 3,5 monophosphate and guanosine 3,5 monophosphate from rat urine. Biochem Biophys Res Commun 1963; 11: 330-334.
6. Kyriakides ZS, Markianos M, Iliodromitis E, Kremastinos DTh. Vein plasma endothelin-1 and c-GMP increase during coronary angioplasty is related to myocardial ischemia. Eur Heart J 1995; 16: 896-898.
7. Vorderwinkler KP, Artner-Dworzak E, Jakob G, Dienstl JNZ, Pichler M. Puschendorf B. Release of cyclic-guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases. Clin Chem 1991; 37: 2.
8. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682-685.
9. Schulz S, Chinkers M, Garbers DL. The Guanylate Cyclase/Receptor Family of Proteins. Fed Am Soc Exp Biol J 1989; 3: 2026-2035.
10. Feldman AM, Bristow MR. The β-adrenergic pathway in the failing human heart: Implications for inotropic therapy. Cardiology 1990; 77(Suppl. 1): 1-32.
11. Feldman AM. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation 1993; 87(Suppl. IV): 27-34.
12. Kunidata S, Honma M, Ui M. Increases in plasma cyclic-AMP dependent on endogenous catecholamines. Eur J Pharmacol 1978; 48: 159-169.
13. Ohyanagi M, Matsumori Y, Iwasaki T. Beta-adrenergic receptors in ischemic and non-ischemic canine myocardium: relation to ventricular fibrillation and effects of pretreatment with propranolol and hexamethonium. J Cardiovasc Pharmacol 1988; 11: 107-114.
14. Theodorakis G, Kremastinos DTh, Markianos M, Livanis E, Karavolias G, Toutouzas P. Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise. Eur Heart J 1992; 13: 1477-1481.
15. Kondo T, Ogawa K, Ban M, Ogasawara B, Watanabe E, Satake T. Plasma level of norepinephrine and cyclic-nucleotides following acute myocardial infarction. Jpn Heart J 1981; 22(4): 593-603.
16. Ahlner J, Andersson RGG, Axelsson KL, Bergdahl B, Dahstrohm U, Swahn E. Decreased plasma levels of cyclic-GMP in patients with chest pain and angiographically normal coronary arteries. Klin Wochenschr 1988; 66: 494-497.
17. Williams RH, Barish J, Ensicnk JW. Hormone effects upon cyclic nucleotide excretion in man. Proc Soc Exp Biol Med 1972; 139: 447-454.
18. Parrat J, Vog LA. Pronounced antiarrhythmic effects of ischemic preconditioning. Cardioscience 1994; 5(1): 9-18.
19. Henderson AH. Endothelium in control. Br Heart J 1991; 65: 116-125.
20. Pohl U, Busse R. EDRF increases cyclic-GMP in platelets during passage through the coronary vascular bed. Circ Res 1989; 65: 1798-803.
21. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329(27): 2002-2012.
22. Salvemini D, Masini E, Anggard E, Mannaioni PF, Vane J. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: Stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem Biophys Res Commun 1990; 169: 596-601.
23. Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell. An endothelial paradigm. Circ Res 1993; 72: 239-245.
24. Ohno M, Gibbons GH, Dzau VJ, Cooke JP. Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling. Circulation 1993; 88: 193-197.
25. Christie MI, Griffith TM, Lewis MJ. A comparison of basal and agonist-stimulated release for endothelium-derived relaxing factor from different arteries. Br J Pharmacol 1989; 98: 397-406.
26. Schmidt K, Mayer JB, Kukovetz WR. Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells. Eur J Pharmacol 1989; 170: 157-166.
27. Karlsberg RP, Penkoske PE, Corr PB, Roberts R. Rapid activation of sympathetic nervous system following coronary artery occlusion: Relationship to infarct size, site, and hemodynamic infarct. Cardiovasc Res 1979; 13: 523-553.
28. Malatino LS, Leonardi C, Stancanelli B et al. Transient myocardial ischaemia stimulates atrial natriuretic factor release. Am Heart J 1992; 123: 693-698.